E/M Coding Alert - 2006 Issue 11
PART D: Pharmas Work To Cover 'Doughnut Hole' For Low-Income Benes
Subscribe or sign in to view the full article.
Article Overview
This article examines a proposed industry coalition program designed to reduce prescription drug costs for qualifying Medicare Part D beneficiaries who reach the coverage gap. It explains the general eligibility concept, the scale of the initiative, the companies involved, and the compliance concerns raised by the HHS Office of Inspector General regarding discounts, drug choice, and safeguards against abuse. The piece is relevant to readers tracking Medicare Part D policy, pharmaceutical assistance programs, and federal fraud-and-abuse oversight.
Why This Topic Matters
The proposal could affect how low-income Medicare beneficiaries access prescription drugs during the Part D coverage gap, while also highlighting regulatory issues that health plans, drug manufacturers, and compliance teams must consider.
What You Will Learn
- The general purpose of the proposed prescription drug discount coalition
- Who the proposal is intended to help
- Why the initiative raises federal oversight and anti-kickback concerns
- What kinds of safeguards regulators say are important
- Which types of stakeholders are likely to be affected by the proposal
Who Should Read This
- Medicare compliance professionals
- Health plan administrators
- Pharmacy benefit stakeholders
- Medical coders and auditors tracking policy updates
- Healthcare attorneys and fraud-and-abuse compliance teams
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com